Sapien M3 TMVR Easily Beats Expectations in Pivotal Trial

By News Health
3 months Ago

(MedPage Today) — SAN FRANCISCO — For selected patients with mitral regurgitation (MR), the Sapien M3 device delivered highly promising 1-year outcomes for the desperate field of transcatheter mitral valve replacement (TMVR).
Following the…

Source link : https://www.medpagetoday.com/meetingcoverage/tct/118208

Author :

Publish date : 2025-10-29 16:42:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Regional Anesthesia: Key to Better Postoperative Outcomes?

First leukaemia patient to get pioneering drug on NHS says it is 'very sci-fi'

These small lifestyle tweaks can add a year to your life

MicroRNA Tests Eyed for Flagging Heart Transplant Rejection

Experts Alarmed by USPSTF Work Slowdown

'Dry January' Offers a Shot of Stigma